Pharmaceutical composition of dimethylguanidino valeric acid and plant flavonoids for treating chronic inflammatory diseases and cancer
US11744815B1 · kind B1 · utility
0Cited by
0References
4Claims
0Family size
Inventor
Key dates
| Filing date | May 17, 2022 |
| Grant date | Sep 5, 2023 |
| Priority date | — |
| Expiry date | May 17, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the technical field of disease treatment, and more specifically, it relates to a pharmaceutical composition, having arginine metabolite dimethylguanidino valeric acid (DMGV) or plant flavonoids to treat chronic inflammatory and cancers. Disclosed in the present invention are plant flavonoids including kaempferol, daidzein, and quercetin. Treated chronic inflammatory diseases include rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and cancer further including hematological cancers as well as solid tumor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.